Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Pulmonary and Respiratory Medicine journal rankings 2014
283 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 283 ranked journals in 2014. The median journal has an OJR of 0.75, below the world average of 1.00, down 0.02 on 2013; Q1 starts at OJR 1.35. The top three are European Urology, Cochrane Database of Systematic Reviews, and American Journal of Respiratory and Critical Care Medicine.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
Show all 42 subfields
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
283 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1European UrologyElsevier BV · Switzerland | 4.70Q1 | 10.78 0.77 up from 2013 | 1,093 | 15% | $5,250 | ||
2Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 4.29Q1 | 8.54 0.81 up from 2013 | 2,314 | 53% | $5,100 | ||
3American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 3.64Q1 | 8.45 0.47 up from 2013 | 1,595 | 38% | — | ||
4The Lancet Respiratory MedicineElsevier BV · Netherlands | 3.30Q1 | 6.08 0.48 up from 2013 | 167 | 36% | $7,280 | ||
5Annals of Intensive CareOASpringer Nature · France | 2.99Q1 | 4.94 0.52 down from 2013 | 162 | 100% | $3,490 | ||
6Modern PathologyElsevier BV · United States | 2.91Q1 | 6.41 0.61 down from 2013 | 592 | 99% | $4,480 | ||
7CHEST JournalElsevier BV · United States | 2.77Q1 | 6.20 0.14 up from 2013 | 2,060 | 21% | $4,160 | ||
8Seminars in PerinatologyElsevier BV · United States | 2.71Q1 | 4.32 0.24 down from 2013 | 180 | 13% | $4,370 | ||
9European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 2.64Q1 | 5.68 0.61 up from 2013 | 184 | 100% | — | ||
10DrugsAdis, Springer Healthcare · New Zealand | 2.61Q1 | 5.98 0.34 up from 2013 | 448 | 21% | $5,990 | ||
11Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 2.56Q1 | 4.60 0.87 down from 2013 | 180 | 19% | $4,590 | ||
12Intensive Care MedicineSpringer Science+Business Media · Germany | 2.54Q1 | 6.82 2.00 up from 2013 | 984 | 49% | $5,190 | ||
13Fibrogenesis & Tissue RepairBioMed Central · United Kingdom | 2.39Q1 | 5.77 0.70 up from 2013 | 95 | 100% | — | ||
14Journal of Thoracic OncologyElsevier BV · United States | 2.34Q1 | 5.18 0.61 down from 2013 | 988 | 97% | $4,100 | ||
15The Journal of UrologyLippincott Williams & Wilkins · United States | 2.27Q1 | 4.67 0.50 up from 2013 | 2,403 | 4% | $3,000 | ||
16European Respiratory JournalEuropean Respiratory Society | 2.14Q1 | 5.33 0.54 up from 2013 | 1,514 | 11% | — | ||
17Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 2.09Q1 | 3.66 0.83 down from 2013 | 279 | 16% | — | ||
18ThoraxBMJ · United Kingdom | 2.04Q1 | 4.51 0.43 down from 2013 | 1,051 | 96% | — | ||
19Seminars in Respiratory and Critical Care MedicineThieme Medical Publishers (Germany) · United States | 1.99Q1 | 3.96 0.18 down from 2013 | 231 | 7% | — | ||
20Respiratory ResearchOABioMed Central · United Kingdom | 1.96Q1 | 4.30 0.36 down from 2013 | 423 | 100% | $3,490 | ||
21Clinics in Chest MedicineElsevier BV · United States | 1.96Q1 | 3.58 0.27 up from 2013 | 193 | 13% | $3,350 | ||
22International Journal of COPDOADove Medical Press · New Zealand | 1.95Q1 | 4.15 0.06 up from 2013 | 235 | 100% | $2,836 | ||
23Journal of Aerosol ScienceElsevier BV · United Kingdom | 1.94Q1 | 2.51 0.36 down from 2013 | 315 | 17% | $2,850 | ||
24Radiotherapy and OncologyElsevier BV · Netherlands | 1.92Q1 | 5.15 0.17 up from 2013 | 1,009 | 4% | $3,770 | ||
25Radiologic Clinics of North AmericaElsevier BV · United States | 1.90Q1 | 3.30 0.43 down from 2013 | 200 | 2% | $3,000 | ||
26International Journal of Radiation Oncology*Biology*PhysicsElsevier BV · United States | 1.89Q1 | 4.20 0.08 up from 2013 | 2,059 | 43% | $4,130 | ||
27Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 1.86Q1 | 4.08 0.66 up from 2013 | 119 | 4% | — | ||
28British Journal of UrologyWiley · United Kingdom | 1.85Q1 | 3.71 0.01 up from 2013 | 2,025 | 31% | $4,770 | ||
29Occupational and Environmental MedicineBMJ · United Kingdom | 1.84Q1 | 3.39 0.29 up from 2013 | 445 | 83% | — | ||
30American Journal of Respiratory Cell and Molecular BiologyAmerican Thoracic Society · United States | 1.83Q1 | 4.41 0.20 down from 2013 | 616 | 69% | — | ||
31Current Opinion in Pulmonary MedicineLippincott Williams & Wilkins · United States | 1.81Q1 | 3.68 0.11 down from 2013 | 270 | 11% | — | ||
32SarcomaHindawi Publishing Corporation · United Kingdom | 1.79Q1 | 4.02 0.53 up from 2013 | 153 | 100% | $820 | ||
33Gastrointestinal EndoscopyElsevier BV · United States | 1.78Q1 | 4.33 0.26 up from 2013 | 1,371 | 7% | $3,450 | ||
34Respiratory MedicineElsevier BV · United Kingdom | 1.78Q1 | 3.81 0.04 down from 2013 | 764 | 100% | $3,630 | ||
35Gastric CancerSpringer Science+Business Media · Japan | 1.77Q1 | 3.02 1.48 down from 2013 | 313 | 87% | $3,590 | ||
36Genes Chromosomes and CancerWiley · United States | 1.76Q1 | 4.38 0.01 up from 2013 | 331 | 23% | $4,810 | ||
37Journal of Cystic FibrosisElsevier BV · Netherlands | 1.74Q1 | 3.59 0.18 down from 2013 | 370 | 99% | $4,370 | ||
38Lung CancerElsevier BV · Netherlands | 1.74Q1 | 4.24 0.19 up from 2013 | 790 | 12% | $3,390 | ||
39Journal of Vascular SurgeryElsevier BV · United States | 1.69Q1 | 3.21 0.15 down from 2013 | 1,824 | 100% | $4,010 | ||
40Journal of the Korean Gastric Cancer AssociationSouth Korea | 1.61Q1 | 2.72 0.10 up from 2013 | 121 | 100% | — | ||
41BMC Pulmonary MedicineOABioMed Central · United Kingdom | 1.60Q1 | 3.70 0.03 down from 2013 | 216 | 100% | $3,090 | ||
42American Journal of Physiology-Lung Cellular and Molecular PhysiologyAmerican Physical Society · United States | 1.60Q1 | 4.66 0.01 down from 2013 | 630 | 77% | — | ||
43The ProstateWiley · United States | 1.59Q1 | 4.19 0.37 up from 2013 | 498 | 42% | $4,600 | ||
44Current Opinion in UrologyLippincott Williams & Wilkins · United States | 1.57Q1 | 2.97 0.03 down from 2013 | 253 | 15% | — | ||
45Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.57Q1 | 4.48 0.78 up from 2013 | 172 | 37% | $5,190 | ||
46Therapeutic Advances in Chronic DiseaseOASAGE Publishing · United Kingdom | 1.57Q1 | 3.86 1.52 up from 2013 | 66 | 100% | $2,950 | ||
47Clinical Sarcoma ResearchOASpringer Science+Business Media · United Kingdom | 1.55Q1 | 3.39 0.95 up from 2013 | 50 | 100% | $2,290 | ||
48RespirationKarger Publishers · Switzerland | 1.54Q1 | 3.90 1.35 up from 2013 | 425 | 26% | — | ||
49Journal of Photochemistry and Photobiology B BiologyElsevier BV · Netherlands | 1.51Q1 | 3.45 0.08 down from 2013 | 511 | 14% | $4,110 | ||
50Journal of Endovascular TherapySAGE Publishing · United States | 1.51Q1 | 3.30 0.43 down from 2013 | 289 | 7% | $4,400 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
92 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 283
- Window papers (baseline)
- 146,389 +11.7% from indicator year 2011
- Median OJR
- 0.75 -6.7% from indicator year 2011
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.